¹«Á¦ ¹®¼­
 
   
¹«Á¦ ¹®¼­
 
 
 
 
 
³¯Â¥ 2010-12-02
Á¦¸ñ Regulatory Affairs Journal Pharma
³»¿ë Regulatory Affairs Journal Pharma May 2007 Issue (Vol 18 No 5)

Contents
Editorial - Myths about Stem Cell Research

The Failure of Trade Marks to Protect against Parallel Imports
Maureen Kenny says that pharma companies may not be able to use trade marks to curtail parallel imports in the EU for much longer

RAJ Briefing - PDUFA-IV Will Focus on Drug Safety
Peter Charlish examines the evolution of the drug user fee programme in the US

Europe's Plans to Fine Drug Companies
Genevieve Michaux says proposed financial penalties for companies violating EU pharmaceutical rules are too tough

Stem Cell Research in India
Geeta Jotwani talks to RAJ about updated guidelines on stem cell research

The Swedish MPA - Driving Regulation through Learning
Victoria English describes the work of the Swedish Medical Products Agency

Benefit:Risk Assessments for Veterinary Medicines in the EU
Rick Clayton and David Mackay report on key issues in veterinary medicine

°ü·ÃURL : http://www.pjbpubs.com/raj_pharma/index.htm

 
 
 
   
¹«Á¦ ¹®¼­